B-Cell Depletion and Efficacy Outcomes of Ofatumumab Are Consistent Across Different Body Mass Index Categories: Insights from ASCLEPIOS I and II Trials (P9-6.002)
Year: 2024
Type: article
Source: Neurology
Institutions: Washington University in St. Louis, University of California, San Francisco, University of Münster, University of Pennsylvania, Stony Brook University, Vall d'Hebron Hospital Universitari, Centre d'Esclerosi Múltiple de Catalunya, Hôpitaux Universitaires de Strasbourg, Novartis (India), Novartis (Switzerland), University of Basel, University Hospital of Basel
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4394599310